耳念珠菌培养上清中β-D-葡聚糖水平:一项体外与体内初步研究
本研究检测10株耳念珠菌培养上清及对应患者血清中β-D-葡聚糖(BDG)水平,并与两株白色念珠菌对照比较。耳念珠菌上清BDG中位数275 pg/mL,反应性中位数24%,血清BDG诊断耳念珠菌血流感染的敏感性为60%。作者认为耳念珠菌释放BDG较少,可能降低血清BDG诊断敏感性并影响管理方案。
要点
- 耳念珠菌培养上清BDG中位数为275 pg/mL,反应性中位数24%。
- 血清BDG诊断耳念珠菌血流感染的敏感性为60%。
- 所有患者均在采血前中位2天启动棘白菌素类抗真菌治疗。
核心结论
- 耳念珠菌菌株释放的BDG量低于白色念珠菌,可能导致血清BDG诊断耳念珠菌血流感染的敏感性降低,并影响该菌高流行地区的管理方案。
研究设计与样本
- 体外与体内初步研究,纳入10株来自血流感染患者血培养的耳念珠菌菌株,并以2株白色念珠菌作为对照。
- 患者血清BDG检测与血培养采集时间窗为-24至+72小时,BDG检测采用Fungitell法。
主要发现
- 2株白色念珠菌对照上清平均BDG水平为1155 pg/mL(视为100%反应性)。
- 耳念珠菌上清BDG中位数为275 pg/mL(IQR 165-523 pg/mL),反应性中位数24%(范围6%-72%)。
- 体内血清BDG中位数为129 pg/mL(IQR 28-199 pg/mL)。
- 血清BDG诊断耳念珠菌血流感染的敏感性为60%。
- 所有患者均接受棘白菌素类抗真菌治疗,启动时间中位数为采血前2天(IQR -8至0)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Serum (1,3)-beta-d-glucan (BDG) assay is a non-culture-based test recommended for the diagnosis of invasive candidiasis owing to its faster results and higher sensitivity than blood cultures. Its performance might vary for different Candida species. The aim of this study was to determine in vitro levels of BDG in Candida auris culture supernatants and evaluate BDG levels in patients with C. auris candidemia sustained by these stains. METHODS: C. auris strains were collected from blood cultures of patients who had a concomitant (-24 to +72 hours) serum BDG test (Fungitell assay). Supernatants of broth media culture of C. auris strains and two Candida albicans (controls) strains were prepared and tested for BDG. RESULTS: Ten C auris strains were included. Supernatants of two C. albicans considered as controls had a mean BDG level of 1155 pg/mL (considered 100% reactivity). The median BDG level in supernatants of C. auris strains was 275 pg/mL (IQR 165-523 pg/mL), with a median reactivity of 24% (range 6%-72%). In vivo, the median BDG level was 129 pg/mL (IQR, 28-199 pg/mL). Sensitivity of BDG for C. auris candidemia was 60%. All patients received antifungal treatment with an echinocandin initiated a median of 2 days (IQR -8 to 0) before blood collection for BDG. DISCUSSION: Our C. auris strains released lower amounts of BDG when compared to C. albicans. Clinical implications include lower sensitivity of serum BDG for the diagnosis of C. auris candidemia with a consequent impact on management protocols in settings with high prevalence of this species.
引用
- Mikulska M, Furfaro E, Magnasco L, et al. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study. Clin Microbiol Infect. 2022. PMID: 35283316. doi:10.1016/j.cmi.2022.02.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。